Distinct Early Serological Signatures Track with SARS-CoV-2 Survival
As SARS-CoV-2 infections and death counts continue to rise, it remains unclear why some individuals recover from infection, whereas others rapidly progress and die. Although the immunological mechanisms that underlie different clinical trajectories remain poorly defined, pathogen-specific antibodies...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
Elsevier BV
2021
|
Online Access: | https://hdl.handle.net/1721.1/128955 |